A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Synergy Healthcare, Bradenton, Florida

Nature Coast Clinical Research LLC, Inverness, Florida

Jacksonville Center for Clinical, Jacksonville, Florida